Clinical Trial Update: Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating postoperative analgesia in patients undergoing unilateral inguinal hernia repair has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inguinal Hernia
• Postoperative Pain

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2013-08-06